28 March 2022SHTAC begins a new five-year National Institute for Health and Care Research (NIHR) funding award Continue Reading
11 February 2022NICE guidance informed by SHTAC report on Daratumumab in combination for untreated multiple myeloma when stem cell transplant is suitable Continue Reading
1 February 2022SHTAC’s information specialist is co-chair of the InterTASC Information Specialists’ Sub-Group (ISSG)Continue Reading
27 January 2022New online course on using digital tools to improve recruitment and retention in clinical trialsContinue Reading
19 January 2022NICE guidance informed by SHTAC report on Solriamfetol for treating excessive daytime sleepiness caused by narcolepsyContinue Reading
8 December 2021NICE guidance informed by SHTAC report on Dupilumab for treating severe asthmaContinue Reading
2 November 2021NICE guidance informed by SHTAC report on Apalutamide for treating prostate cancerContinue Reading
29 June 2021NICE guidance informed by SHTAC report on Budesonide orodispersible tablet for inducing remission of eosinophilic oesophagitisContinue Reading
8 February 2021CONFIRM trial results - Health economists from SHTAC will assess the cost-effectiveness of the treatment Continue Reading
27 November 2020SHTAC is a partner in the FAIR consortium investigating flagellin as an adjunct therapeutic to enhance antibiotic treatment for pneumoniaContinue Reading
5 October 2020NICE guidance informed by SHTAC report on Pembrolizumab with axitinib for untreated advanced renal cell carcinomaContinue Reading
12 June 2020Digital tools for recruiting and retaining people in randomised controlled trials: A systematic map of the evidence base just publishedContinue Reading
8 April 2020SHTAC to assess effectiveness of COVID-19 diagnostic tests and treatments to inform NICE guidance to the NHSContinue Reading
20 February 2020NICE guidance informed by SHTAC report on Cemiplimab for treating metastatic or locally advanced cutaneous squamous cell carcinomaContinue Reading
24 January 2020SHTAC begins work on a rapid review of the effectiveness of digital tools for recruitment and retention of participants in clinical trialsContinue Reading
4 November 2019SHTAC are recruiting a Research Fellow in Health Technology Assessment & ModellingContinue Reading
17 October 2019NICE guidance informed by SHTAC report on rivaroxaban for preventing major cardiovascular events in people with coronary or peripheral artery diseaseContinue Reading
5 June 2019NICE guidance informed by SHTAC report on atezolizumab in combination for treating advanced non-squamous non-small-cell lung cancer Continue Reading
